儿童肝移植患者哌拉西林血浆与腹腔液群体药代动力学及剂量优化
本研究在31例接受肝移植的儿童中建立哌拉西林血浆与腹腔液的群体药代动力学模型,发现体重和eGFR为显著协变量,腹腔液/血浆AUC0-24h比值中位数为72%。模拟显示根据PK靶标和eGFR,优化方案为300 mg/kg/日(q6h输注3小时)至400 mg/kg/日持续输注,建议结合治疗药物监测。
要点
- 儿童肝移植患者哌拉西林血浆与腹腔液暴露受体重和eGFR显著影响。
- 腹腔液/血浆AUC0-24h比值中位数为72%,手术部位暴露低于血浆。
- 优化剂量为300 mg/kg/日(q6h输注3小时)至400 mg/kg/日持续输注,需结合TDM。
核心结论
- 体重和肾功能可解释儿童肝移植患者哌拉西林PK的部分个体间变异,需更高剂量联合TDM优化血浆和手术部位暴露。
研究设计与样本
- 回顾性、单中心、观察性研究,纳入31例接受肝移植并预防性使用哌拉西林-他唑巴坦的儿童,年龄中位数4岁(4月龄-17岁)。
- 共分析172份血浆和146份腹腔液样本,采用非线性混合效应模型(Monolix)进行群体PK分析,属于Optimome研究的一部分。
主要发现
- 血浆浓度最佳拟合为一室模型伴一级消除,并添加虚拟效应室以描述腹腔液浓度。
- 异速缩放体重(移植前和当前值)和eGFR被确定为显著协变量。
- 腹腔液/血浆AUC0-24h比值中位数为72%(范围45-94%)。
关键数值与推荐
- 模拟显示优化方案范围为300 mg/kg/日(q6h输注3小时)至400 mg/kg/日持续输注,取决于PK靶标(fT>1×MIC或fT>4×MIC)和患者eGFR。
临床怎么用
- 儿童肝移植围手术期预防使用哌拉西林-他唑巴坦时,应考虑更高剂量并结合治疗药物监测以优化血浆和手术部位暴露。
局限性
- 回顾性单中心观察性研究,样本量较小(31例),结果需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Piperacillin-tazobactam is frequently used in children undergoing liver transplantation (LT), yet its pharmacokinetics (PK) in this population remains poorly characterized. We aimed to develop a population pharmacokinetic model for piperacillin in plasma and peritoneal fluid in children undergoing LT and to optimize dosing regimen for this population. We conducted a retrospective, single-center, observational study including all children receiving piperacillin-tazobactam as prophylaxis for LT and had at least one piperacillin concentration in both plasma and peritoneal fluid. PK analysis was conducted using nonlinear mixed effect modeling (Monolix) and was part of Optimome study. We included 31 patients with a median (range) age of 4 years (4 months-17 years). A total of 172 plasma and 146 peritoneal fluid samples were analyzed. Plasma concentrations were best fitted by a one-compartment model with first-order elimination. A virtual effect site compartment was added to adequately describe piperacillin concentrations in plasma and peritoneal fluid. Allometrically scaled body weight (pre-transplant and current values) and glomerular filtration rate (eGFR) were identified as significant covariates. Median (range) peritoneal/plasma AUC0-24h ratio was 72 (45-94) %. Simulations showed that optimal dosing regimens ranged from 300 mg/kg/day (q6h over 3 hours) to 400 mg/kg/day as a continuous infusion, depending on the PK target (i.e., fT>1 × MIC or fT>4 × MIC) and patient eGFR. In children undergoing LT, body weight and renal function explained some of the between subject variability for piperacillin PK. Higher dosing regimen combined with therapeutic drug monitoring is necessary to optimize exposure in plasma and at surgical site.
引用
- de Cacqueray N, Oualha M, Foissac F, et al. Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study. Clin Pharmacol Ther. 2026. PMID: 42216238. doi:10.1002/cpt.70346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。